Inflammatory breast cancer is a rare, invasive type of cancer that accounts for about 1 to 5 percent of diagnosed breast cancers in the United States. Most cases are invasive ductal carcinomas, meaning that they begin in the milk duct cells and spread to the lymphatic vessels in the skin of the breast. Often no lump or tumor is present, which can make inflammatory breast cancer hard to detect in its early stages.
The Don & Erika Wallace Comprehensive Breast Program at Moffitt Cancer Center features a multispecialty team of experts trained specifically in the evaluation and treatment of all types of breast cancer. At Moffitt, inflammatory breast cancer patients have access to medical oncologists, radiologists, fellowship-trained surgeons, radiation oncologists, plastic surgeons, experienced nurses, social workers and many other healthcare professionals.
Our comprehensive, patient-centered approach to cancer treatment is what sets Moffitt apart:
- Our multispecialty team provides patients with a complete range of breast health care services in one place, including everything from screening and diagnostic tests to the latest options in advanced, world-class treatment.
- Our patients and their families have access to an extensive range of support services, including social workers, family advisors, massage therapy, yoga and nutrition counseling.
- Because our team members work closely together to discuss and evaluate each patient at weekly tumor board reviews, treatments and treatment schedules are individualized and more precise, improving survival rates and cosmetic outcomes and reducing the need for secondary surgeries or treatments.
- Moffitt provides long-term care and support for our patients for life through our various wellness and support programs.
In addition, Moffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center – the only one in Florida – and we are widely known for our cutting-edge research. Our clinicians and researchers work together, always looking for new therapy options to implement in clinical trials for the treatment of breast cancers. Through efforts such as these, Moffitt continues to improve cancer survival rates and provide patients with a higher quality of life.
For more information, review our Women’s Oncology TeleTalks, or check out HER Place: the Health Education Resource Place. If you have questions about inflammatory breast cancer and would like to schedule an appointment, please contact us at 1-888-MOFFITT. You do not need to have a referral to make an appointment with us.